Genomic Variants in Members of the Krüppel-Like Factor Gene Family are Associated with Disease Severity and Hydroxyurea Treatment Efficacy in β-Hemoglobinopathies Patients

References

• Weatherall DJ . Towards molecular medicine; reminiscences of the haemoglobin field, 1960–2000. Br. J. Haematol.115(4), 729–738 (2001).
   PubMed Web of Science ®Google Scholar
• Cao A , GalanelloR. Beta-thalassemia. Genet. Med.12(2), 61–76 (2010).
   PubMed Web of Science ®Google Scholar
• Origa R . β-thalassemia. Genet. Med.19(6), 609–619 (2017).
   PubMed Web of Science ®Google Scholar
• Iarovaia OV , KovinaAP , PetrovaNVet al. Genetic and epigenetic mechanisms of β-globin gene switching. Biochemistry (Mosc)83(4), 381–392 (2018).
   PubMed Web of Science ®Google Scholar
• Sankaran VG , OrkinSH. The switch from fetal to adult hemoglobin. Cold Spring Harb. Perspect. Med.3(1), a011643 (2013).
   PubMed Web of Science ®Google Scholar
• Lavelle DE . The molecular mechanism of fetal hemoglobin reactivation. Semin Hematol.41(4; Suppl. 6), 3–10 (2004).
   PubMed Web of Science ®Google Scholar
• Gravia A , ChondrouV , SgourouAet al. Individualizing fetal hemoglobin augmenting therapy for beta-type hemoglobinopathies patients. Pharmacogenomics15(10), 1355–64 (2014).
   PubMed Web of Science ®Google Scholar
• Bordbar MR , SilavizadehS , HaghpanahS , KamfirooziR , BardestaniM , KarimiM. Hydroxyurea treatment in transfusion-dependent β-thalassemia patients. Iran Red Crescent Med. J.16(6), e18028 (2014).
   PubMed Web of Science ®Google Scholar
• Koren A , LevinC , DganyOet al. Response to hydroxyurea therapy in β-thalassemia. Am. J. Hematol.83(5), 366–70 (2008).
   PubMed Web of Science ®Google Scholar
• Wilber A , NienhuisAW , PersonsDA. Transcriptional regulation of fetal to adult hemoglobin switching: new therapeutic opportunities. Blood117(15), 3945–3953 (2011).
   PubMed Web of Science ®Google Scholar
• Gravia A , ChondrouV , KolliopoulouAet al. Correlation of SIN3A genomic variants with β-hemoglobinopathies disease severity and hydroxyurea treatment efficacy. Pharmacogenomics17(16), 1785–1793 (2016).
   PubMed Web of Science ®Google Scholar
• Wyszynski DF , BaldwinCT , ClevesMAet al. Polymorphisms near a chromosome 6q QTL area are associated with modulation of fetal hemoglobin levels in sickle cell anemia. Cell. Mol. Biol. (Noisy-le-grand)50(1), 23–33 (2004).
   PubMed Web of Science ®Google Scholar
• Thein SL , MenzelS , PengXet al. Intergenic variants of HBS1L-MYB are responsible for a major quantitative trait locus on chromosome 6q23 influencing fetal hemoglobin levels in adults. Proc. Natl Acad. Sci. USA104(27), 11346–11351 (2007).
   PubMed Web of Science ®Google Scholar
• Sebastiani P , WangL , NolanVGet al. Fetal hemoglobin in sickle cell anemia: Bayesian modeling of genetic associations. Am. J. Hematol.83(3), 189–195 (2008).
   PubMed Web of Science ®Google Scholar
• Banan M , BayatH , AzarkeivanAet al. The XmnI and BCL11A single nucleotide polymorphisms may help predict hydroxyurea response in Iranian β-thalassemia patients. Hemoglobin36(4), 371–380 (2012).
   PubMed Web of Science ®Google Scholar
• Kumkhaek C , TaylorJG , ZhuJet al. Fetal haemoglobin response to hydroxycarbamide treatment and sar1a promoter polymorphisms in sickle cell anaemia. Br. J. Haematol.141(2), 254–259 (2008).
   PubMed Web of Science ®Google Scholar
• Atkins GB , JainMK. Role of Krüppel-like transcription factors in endothelial biology. Circ. Res.100(12), 1686–1695 (2007).
   PubMed Web of Science ®Google Scholar
• Kaczynski J , CookT , UrrutiaR. Sp1- and Krüppel-like transcription factors. Genome Biol.4(2), 206 (2003).
   PubMed Web of Science ®Google Scholar
• Suske G , BrufordE , PhilipsenS. Mammalian SP/KLF transcription factors: bring in the family. Genomics85(5), 551–556 (2005).
   PubMed Web of Science ®Google Scholar
• Alhashem YN , VinjamurDS , BasuM , KlingmüllerU , GaenslerKM , LloydJA. Transcription factor KLF1, KLF2 positively regulate fetal and embryonic beta globin gene through direct promoter binding. J. Biol. Chem.286(28), 24819–27 (2011).
   PubMed Web of Science ®Google Scholar
• Chang E , NayakL , JainMK. Krüppel-like factors in endothelial cell biology. Curr. Opin. Hematol.24(3), 224–229 (2017).
   PubMed Web of Science ®Google Scholar
• McConnell BB , YangVW. Mammalian Krüppel-like factors in health and diseases. Physiol. Rev.90(4), 1337–1381 (2010).
   PubMed Web of Science ®Google Scholar
• Pearson R , FleetwoodJ , EatonS , CrossleyM , BaoS. Krüppel-like transcription factors: a functional family. Int. Biochem. Cell. Biol.40(10), 1996–2001 (2008).
   PubMed Web of Science ®Google Scholar
• Xiong Q , ZhangZ , ChangKH. Comprehensive characterization of erythroid-specific enhancers in the genomic regions of human Krüppel-like factors. BMC Genomics14(1), 587 (2013).
   PubMedGoogle Scholar
• Funnell AP , MakKS , TwineNA. Generation of mice deficient in both KLF3/BKLF and KLF8 reveals a genetic interaction and a role for these factors in embryonic globin gene silencing. Mol. Cell. Biol.33(15), 2976–2987 (2013).
   PubMed Web of Science ®Google Scholar
• Funnell AP , MaloneyCA , ThompsonLJ. Erythroid Krüppel-like factor directly activates the basic Krüppel-like factor gene in erythroid cells. Mol. Cell. Biol.27(7), 2777–2790 (2007).
   PubMed Web of Science ®Google Scholar
• Funnell AP , VernimmenD , LimWF. Differential regulation of the α-globin locus by Krüppel-like factor 3 in erythroid and non-erythroid cells. BMC Mol. Biol.15(1), 8 (2014).
   PubMedGoogle Scholar
• Chondrou V , KolovosP , SgourouAet al. Whole transcriptome analysis of human erythropoietic cells during ontogenesis suggests a role of VEGFA gene as modulator of fetal hemoglobin and pharmacogenomic biomarker of treatment response to hydroxyurea in β-type hemoglobinopathy patients. Hum. Genomics11(1), 24 (2017).
   PubMedGoogle Scholar
• Musallam KM , TaherAT , RachmilewitzEA. β-thalassemia intermedia: a clinical perspective. Cold Spring Harb. Perspect. Med.2(7), a013482 (2012).
   PubMed Web of Science ®Google Scholar
• Dixit A , ChatterjeeTC , MishraPet al. Hydroxyurea in thalassemia intermedia – a promising therapy. Ann. Hematol.84(7), 441–446 (2005).
   PubMed Web of Science ®Google Scholar
• Borg J , PhylactidesM , BartsakouliaMet al. KLF10 gene expression is associated with high fetal hemoglobin levels and with response to hydroxyurea treatment in β-hemoglobinopathy patients. Pharmacogenomics13(13), 1487–1500 (2012).
   PubMed Web of Science ®Google Scholar
• Elalfy MS , ElSherif NH , KamalTM , AlyNH. Klf10 gene, a secondary modifier and a pharmacogenomic biomarker of hydroxyurea treatment among patients with hemoglobinopathies. J. Pediatr. Hematol. Oncol.39(3), e155–e162 (2017).
   PubMed Web of Science ®Google Scholar
• Xu Z , TaylorJA. SN Pinfo: integrating GWAS and candidate gene information into functional SNP selection for genetic association studies. Nucleic Acids Res.37(Web Server issue), W600–W605 (2009).
   PubMed Web of Science ®Google Scholar
• SNPinfo . https://snpinfo.niehs.nih.gov/snpinfo/snptag.html
   Google Scholar
• Ota M , AsamuraH , OkiT , SadaM. Restriction enzyme analysis of PCR products. Methods Mol. Biol.578, 405–414 (2009).
   PubMedGoogle Scholar
• Sanger F , NicklenS , CoulsonAR. DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA74(12), 5463–7 (1977).
   PubMed Web of Science ®Google Scholar
• Goodman SN . Toward evidence-based medical statistics. 1: the p value fallacy. Ann. Intern. Med.130(12), 995–1004 (1999).
   PubMed Web of Science ®Google Scholar
• Payen E , LeboulchP. Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies. Hematology Am. Soc. Hematol. Educ. Program2012(1), 276–283 (2012).
   PubMedGoogle Scholar
• United States Food and Drug Administration (FDA). www.fda.gov/Drugs/InformationOnDrugs/ApprovedDrugs/ucm590096.htm
   Google Scholar
• Funnell AP , NortonLJ , MakKSet al. The CACCC-binding protein KLF3/BKLF represses a subset of KLF1/EKLF target genes and is required for proper erythroid maturation in vivo . Mol. Cell. Biol. 32(16), 3281–3292 (2012).
   PubMed Web of Science ®Google Scholar
• Zhang P , BasuP , RedmondLCet al. A functional screen for Krüppel-like factors that regulate the human γ-globin gene through the CACCC promoter element. Blood Cells Mol. Dis.35(2), 227–235 (2005).
   PubMed Web of Science ®Google Scholar
• Marini MG , PorcuL , AsunisIet al. Regulation of the human HBA genes by KLF4 in erythroid cell lines. Br. J. Haematol.149(5), 748–758 (2010).
   PubMed Web of Science ®Google Scholar
• Kalra IS , AlamMM , ChoudharyPK , PaceBS. Krüppel-like factor 4 activates HBG gene expression in primary erythroid cells. Br. J. Haematol.154(2), 248–259 (2011).
   PubMed Web of Science ®Google Scholar
• ENSEMBL. www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=8:102652785-102653785;v=rs980112;vdb=variation;vf=381157064
   Google Scholar
• ENSEMBL. www.ensembl.org/Homo_sapiens/Variation/Population?db=core;r=8:102649491-102650491;v=rs3191333;vdb=variation;vf=381248861
   Google Scholar
• Siatecka M , BiekerJJ. The multifunctional role of EKLF/KLF1 during erythropoiesis. Blood118(8), 2044–2054 (2011).
   PubMed Web of Science ®Google Scholar
• Zhang JS , MoncrieffeMC , KaczynskiJ , EllenriederV , PrendergastFG , UrrutiaR. A conserved α-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A. Mol. Cell. Biol.21(15), 5041–5049 (2001).
   PubMed Web of Science ®Google Scholar
• Strouse JJ , HeeneyMM. Hydroxyurea for the treatment of sickle cell disease: efficacy, barriers, toxicity, and management in children. Pediatr. Blood Cancer59(2), 365–371 (2012).
   PubMed Web of Science ®Google Scholar
• Ventola CL . Role of pharmacogenomic biomarkers in predicting and improving drug response: part 1: the clinical significance of pharmacogenetic variants. P T.38(9), 545 (2013).
   PubMedGoogle Scholar
• Hong J , StamatoyannopoulosG , SongCZ. Regulation of globin gene expression and erythroid differentiation by Sp/KLF factors. Blood106(11), 4241 (2005).
   PubMed Web of Science ®Google Scholar
• Pule GD , MowlaS , NovitzkyN , WonkamA. Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease. Clin. Transl. Med.5(1), 15 (2016).
   PubMedGoogle Scholar
• Norton LJ , FunnellAP , BurdachJet al. KLF1 directly activates expression of the novel fetal globin repressor ZBTB7A/LRF in erythroid cells. Blood Adv.1(11), 685–692 (2017).
   PubMed Web of Science ®Google Scholar
• Fathallah H , WeinbergRS , GalperinY , SuttonM , AtwehGF. Role of epigenetic modifications in normal globin gene regulation and butyrate-mediated induction of fetal hemoglobin. Blood110(9), 3391–3397 (2007).
   PubMed Web of Science ®Google Scholar
• Ginder GD . Epigenetic regulation of fetal globin gene expression in adult erythroid cells. Transl. Res.165(1), 115–125 (2015).
   PubMed Web of Science ®Google Scholar
• Kolliopoulou A , SiamoglouS , JohnAet al. Role of genomic biomarkers in increasing fetal hemoglobin levels upon hydroxyurea therapy and in β- thalassemia intermedia: a validation cohort study. Hemoglobin43(1), 27–33 (2019).
   PubMed Web of Science ®Google Scholar